OncoSec Medical Incorporated ONCS
$ 0.28
31.87%
Quarterly report 2022-Q3
added 12-15-2022
Country |
USA |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. Daniel O'Connor |
Employees in the company |
42 |
Shares |
39.3 M |
Market Cap[1] |
$ 1.61 M |
EBITDA (LTM) |
$ -37.1 M |
P/E (LTM) |
-0.37 |
P/S (LTM) |
- |
EPS (LTM) |
-5.28 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.